Return to program book search
Hidradenitis Suppurativa: An Update
Ticket required for admission, no tuition fee. Ticket holds seat for only 15 minutes after the official start time.
Friday, August 17
1:00 PM - 2:30 PM
Ginette Hinds, MD, FAAD
Following this course, the attendee should be able to:
- Discuss the pathogenesis, clinical presentation, and epidemiology of hidradenitis suppurativa.
- Summarize current medical and surgical therapeutic options.
- Formulate and prescribe a treatment plan based on the current medical literature.
Hidradenitis suppurativa is a chronic, recurrent, scarring inflammatory dermatosis. It is a common disease that is associated with considerable morbidity and often poses significant challenges for the practitioner. Its pathogenesis and clinical presentation will be reviewed. Standard and newer therapeutic options, including antimicrobial therapy, hormone therapy, biologics, surgical and laser procedures, will be discussed. After this presentation, the audience will be able to diagnose and accurately stage the disease, describe its natural history, and summarize current therapies. They will be able to apply this information to develop a rational
treatment algorithm for this often difficult to treat disease.